Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1424 (LINC01424)
- Target
- LINC01424
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Other (regulatory RNA transcript)
01
Overview
LINC01424 (long intergenic non-protein coding RNA 1424) is a member of the lincRNA class, defined as a long non-protein coding RNA more than 200 nucleotides in length that does not overlap with annotated protein-coding genes[1][5][7]. LINC01424 is autonomously transcribed from an intergenic locus, but its specific biological role remains unknown. In general, long intergenic non-coding RNAs (lincRNAs) can regulate gene expression through a variety of mechanisms, such as influencing chromatin structure, recruiting transcriptional co-factors, stabilizing RNAs, and acting as enhancer-like elements[5][7]. As of now, there is no evidence for LINC01424 being used directly as a therapeutic target, possessing disease specificity, or serving as a clinical biomarker[1][3]. Its potential biological functions and disease roles remain to be clarified by future research.
- Other names
- LINC01424Long intergenic non-protein coding RNA 1424
02
Mechanism of action
Not applicable. There are no drugs targeting LINC01424, so mechanisms of action are not described[1][3].
03
Biological functions
Chromatin remodelingTranscription regulationRNA stabilizationModulation of gene expressionPotential enhancer-like activity
04
Disease associations
No disease associations for LINC01424 specifically are described in searchable literature or gene databases[1][3]. In general, lincRNAs as a class have been implicated in various disease contexts (e.g., cancer, development, gene regulation)[5][7], but LINC01424 itself is not specifically annotated for any disease.
05
Safety considerations
None documented. As it is not implicated in therapy or biomarker-based patient stratification, no safety concerns are available for LINC01424[1][3].
06
Interacting drugs
None known. There are no reported drugs or small molecules directly interacting with LINC01424[1][3].
07
Biomarkers
None known. LINC01424 is not cited as a patient selection or efficacy biomarker in major clinical or genomics sources[1][3].
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1424 (LINC01424).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1424 (LINC01424).